This is a news story, published by MSN, that relates primarily to Medical Research Institute news.
For more biology news, you can click here:
more biology newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
gene therapy products. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Molecular Therapy news, new viral vectors news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Chimeric antigen receptorMedical Xpress - medical research advances and health news
•
79% Informative
Children's Medical Research Institute scientists have identified a new method for producing a therapeutic product that has the potential to improve the treatment of cancer.
Chimeric antigen receptor ( CAR ) T cells, also known as CAR T therapies, are a relatively new form of treatment showing very exciting results for several types of cancer, including solid tumors.
VR Score
88
Informative language
95
Neutral language
48
Article tone
formal
Language
English
Language complexity
73
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links